Thursday, May 18, 2023 12:15 AM
NEW YORK—The readers of Vision Monday
and 20/20 Magazine
are being asked to share their choices
for great business support partners in another challenging business year, via the new Ultimate Partners program. Nominations for 2023 have been coming in over the past several weeks and the deadline for submissions has been extended until 11:59 p.m., ET, on May 24. Readers are being asked to recall when they were facing a critical challenge, in 2022 and into this year, and to salute the business partner who showed up at the right moment to reshape that problem into an opportunity or name which supplier, or representative, came to the rescue with valuable new solutions.
Friday, May 5, 2023 12:18 AM
SYDNEY, Australia—The International Myopia Institute
(IMI) has launched the third series of their highly cited White Papers in a special issue of the top peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.
Thursday, April 27, 2023 12:18 AM
WALTHAM, Mass.—Apellis Pharmaceuticals, Inc.
has announced a new campaign with acclaimed actor Henry Winkler to raise awareness of geographic atrophy (GA), an advanced form of age-related macular degeneration and a leading cause of blindness.
Tuesday, April 18, 2023 12:18 AM
SARASOTA, Fla.—US Eye
, a Sarasota-based network of premium eyecare practices, announced that 16 US Eye physicians have been named to the 2023 list of Top Doctors
published by Castle Connolly Medical.
Monday, April 3, 2023 12:24 AM
CHICAGO—Two out of every three people living with blindness or vision problems are women, according to the National Eye Institute
. That’s why Prevent Blindness
, the nation’s leading nonprofit eye health organization, has declared April as Women’s Eye Health and Safety Month. Because many of the effects of vision loss from eye disease can be lessened if detected and treated early, the group offers a variety of expert-reviewed free resources, including videos, fact sheets and shareable social media graphics on a range of eye health issues.
By Mary Kane
Friday, March 24, 2023 3:00 PM
Nearly three years to the day of when lockdowns began during the COVID-19 pandemic, the Javits Center opened its doors on March 17 to thousands of vendors, buyers, eyecare professionals and industry leaders. “This is the first year where it feels like the energy is back,” VSP Vision’s Stevie Mitchell keenly observed. Vision Expo East was the largest gathering of ophthalmic professionals in the U.S. in recent years. The Show, which ran from March 16 -19, welcomed thousands from the international vision care industry. Read on for a recap of some of Expo’s major highlights as well as photos of some of the many Show Floor events.
Friday, February 10, 2023 12:24 AM
ORLANDO—Ascend Vision Partners
(AVP) has announced the acquisition of Cohn Eye Center
and R&E Optical
, adding two more premier vision groups to its partnership portfolio. “We are privileged to have partnered with such an outstanding group,” said Chad Tomlinson, chief development officer at Ascend Vision Partners. “Founded by Dr. Richard Cohn, Cohn Eye Center and R&E Optical set the standard for eyecare in Central Florida. I know that together we will continue to build a best-in-class vision platform.” Ascend Vision Partners currently has 11 practices with 19 total locations across the Southeast.
By Mary Kane
Friday, January 13, 2023 8:30 AM
According to the Centers for Disease Control and Prevention, about three million Americans have glaucoma and the disease is the second leading cause of blindness worldwide. January is officially National Glaucoma Awareness month and during this time, it’s important to spread the word about this group of diseases that affects many Americans every year. VMAIL Weekend
recently sat down with Ashish Singh, MD, who specializes in cataract and refractive surgery at Kleiman Evangelista Eye Centers. Here’s what he had to say about the early signs of glaucoma, encouraging high-risk patients to get screened on a regular basis and new glaucoma treatments.
Friday, January 13, 2023 12:21 AM
CUMBERLAND, R.I.—Neurotech Pharmaceuticals, Inc.
, a clinical stage biotech company, announced the expansion of its executive team with the appointment of Scott Hunter as chief commercial officer bringing two decades of eyecare experience across both rare disease and specialty markets. "Scott’s appointment as the company’s first chief commercial officer marks an important milestone for Neurotech.
Wednesday, December 21, 2022 12:27 AM
LAKE FOREST, Calif.—STAAR Surgical Company
, a leading developer, manufacturer and marketer of implantable lenses for the eye, announced that president and CEO Caren Mason will be retiring on Dec. 31, 2022, after leading the company through a significant period of revitalization and growth for more than seven years.
Monday, December 19, 2022 12:18 AM
NEW PROVIDENCE, N.J.—Prism Vision Group
(PVG), the large vertically integrated eye care services organization operating exclusively on the East Coast, has welcomed Lakeview Surgery Center
, Bowie, Md., to its growing platform of both ophthalmology practices and surgery centers. Lakeview Surgery Center, a 9,900-square-foot facility that showcases two operating suites, exclusively provides ophthalmic surgery five days per week. Its clinical leadership includes Medical Director, Dr. Alyson Hall, and Drs. Jonathan Solomon, John Choi, and Omar Ahmad.
Thursday, December 15, 2022 8:30 AM
BOSTON and DURHAM, N.C.—Parexel
, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today has announced a formal agreement with MyEyeDr.
, a leading vision healthcare organization with over 850 offices across the U.S., to refer its patients into existing and future ophthalmology clinical trials. Parexel and MyEyeDr. are currently collaborating on recruitment for a diabetic retinopathy clinical trial with future plans to expand into additional therapeutic areas such as endocrinology.
Monday, December 5, 2022 12:15 AM
IRVINE, Calif.—New research from the University of California, Irvine
, suggests aging is an important component of retinal ganglion cell death in glaucoma, and that novel pathways can be targeted when designing new treatments for glaucoma patients.